Literature DB >> 20189287

Optimal primary minimally invasive treatment for patients with stress urinary incontinence and symptomatic pelvic organ prolapse: tension free slings with colporrhaphy, or Prolift with the tension free midurethral sling?

Ivan Ignjatovic1, Ivica Stojkovic, Dragoslav Basic, Nina Medojevic, Milan Potic.   

Abstract

OBJECTIVE: Comparison of procedures in patients with concomitant stress urinary incontinence (SUI) and pelvic organ prolapse (POP) was performed. Tension free vaginal tape (TVT) or transobturator tape (TOT) with colporrhaphy was compared with fixed mesh (Prolift) applied with a tension free suburethral sling. STUDY
DESIGN: A total of 76 women with both SUI and POP were evaluated. TVT or TOT with colporrhaphy was performed in 39 patients and Prolift with the midurethral sling in 37 patients. Anatomy, symptoms and quality of life (QOL) were evaluated prior to, and at 1, 6 and 12 months after surgery.
RESULTS: Continence was achieved in both groups equally (p=0.57). The better anatomic outcome regarding the correction of POP was in the Prolift group but with a higher rate of additional procedures and complications. QOL was better in patients with grade III-IV POP corrected with Prolift (p=0.05) and equal in both groups with grade I-II POP during the follow-up. Impairment of sexual life was present in both groups before surgery. After surgery, there was no improvement in sexual life regardless of correction of both anatomy and incontinence.
CONCLUSION: Both procedures are effective and safe. TVT or TOT performed with colporrhaphy looks a better primary choice for grade II POP and SUI. Results for grade III-IV POP and SUI are better with the Prolift with the sling. Sexual life could not be improved effectively with these types of surgery. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20189287     DOI: 10.1016/j.ejogrb.2010.01.009

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  7 in total

1.  The scientific rationale for using biomaterials in stress urinary incontinence and pelvic organ prolapse.

Authors:  Tristan Keys; Gopal Badlani
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

2.  Initial experience with concomitant prolift™ system and tension-free vaginal tape procedures in patients with stress urinary incontinence and cystocele.

Authors:  Hyoung-Keun Park; Sung-Hyun Paick; Byung-Ki Lee; Myung-Beom Kang; Kyung-Kyu Jun; Hyeong-Gon Kim
Journal:  Int Neurourol J       Date:  2010-04-30       Impact factor: 2.835

Review 3.  Vaginal Mesh Exposure Presentation, Evaluation, and Management.

Authors:  Joao P Zambon; Gopal H Badlani
Journal:  Curr Urol Rep       Date:  2016-09       Impact factor: 3.092

4.  Lack of effect of concomitant stage II cystocele repair on lower urinary tract symptoms and surgical outcome after tension-free vaginal tape procedure: randomized controlled trial.

Authors:  Hyoung Keun Park; Sung Hyun Paick; Yong Soo Lho; Gwoan Youb Choo; Hyeong Gon Kim; Jaekyung Choi
Journal:  Int Urogynecol J       Date:  2012-11-03       Impact factor: 2.894

Review 5.  The Novel and Minimally Invasive Treatment Modalities for Female Pelvic Floor Muscle Dysfunction; Beyond the Traditional

Authors:  Yiğit Akın; Matthew Young; Muhammad Elmussareh; Nickolaus Charalampogiannis; Ali Serdar Gözen
Journal:  Balkan Med J       Date:  2018-06-28       Impact factor: 2.021

6.  Mesh complications in female pelvic floor reconstructive surgery and their management: A systematic review.

Authors:  Hemendra N Shah; Gopal H Badlani
Journal:  Indian J Urol       Date:  2012-04

7.  Stress Urinary Incontinence and Pelvic Organ Prolapse Correction by Single Incision and Using Monoprosthesis: Three-year Follow-up.

Authors:  Mahtab Zargham; Narjes Saberi; Mohammad Hatef Khorrami; Mehrdad Mohamadi; Kia Nourimahdavi; Mohammad Hosein Izadpanahi
Journal:  Adv Biomed Res       Date:  2018-12-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.